GlassScriptPhysician profile
Scott B Seibert
NPI 1962713792
$11,452.59
in general payments reported to CMS, 2019-2025
33 companies · $1,836 in 2025
The $1,836 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,210 · 2020: $45.12 · 2021: $1,721 · 2022: $4,194 · 2023: $1,330 · 2024: $1,117 · 2025: $1,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,172 · Food and Beverage: $2,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,171.53 |
| Food and Beverage | $2,111.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prime Surgical, LLC | $3,278.89 | 2022-2025 | |
| Arthrex, INC. | $3,246.63 | 2022-2025 | Distal Extremities Implants Trauma |
| Evolution Surgical, INC | $1,200.00 | 2021 | |
| Acell, INC. | $894.00 | 2019 | |
| Depuy Synthes Sales INC. | $856.51 | 2021-2025 | Na, Intrafix, Dynatape |
| Smith+Nephew, INC. | $384.58 | 2022-2024 | Evos, Maverick, Trigen Intertan |
| Stryker Corporation | $313.51 | 2019-2021 | |
| Medical Device Business Services, INC. | $122.11 | 2024 | Na |
| Zimmer Biomet Holdings, INC. | $106.16 | 2021-2023 | Juggerknotless Soft Anchor, Juggerstitch, Tricera Handpiece |
| Encore Medical, LP | $105.29 | 2021-2022 | |
| Amgen INC. | $101.75 | 2024-2025 | Krystexxa |
| Illuminoss Medical, INC. | $84.20 | 2024 | |
| Bioventus LLC | $74.65 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Microport Orthopedics INC | $70.21 | 2019 | |
| Pfizer INC. | $68.63 | 2023-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Ethicon US, LLC | $58.05 | 2022-2024 | Stratafix, Vistaseal |
| Globus Medical, INC. | $47.96 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $43.92 | 2023 | Seglentis |
| Atland Pharmaceuticals, LLC | $39.84 | 2025 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Orthofix Medical, INC. | $37.26 | 2024-2025 | Cervical-Stim |
| Boston Scientific Corporation | $33.77 | 2025 | Wavewriter Alpha Prime 16 |
| Providence Medical Technology, INC. | $30.16 | 2025 | |
| Biocomposites INC | $29.59 | 2025 | Stimulan |
| Molnlycke Health Care US, LLC | $25.70 | 2025 | Mepilex Border Post-Op Ag, Avance |
| Vertex Pharmaceuticals Incorporated | $21.70 | 2025 | |
| Convatec INC. | $18.75 | 2022 | |
| Solventum Corporation | $18.67 | 2024 | V.A.C.Ulta, Prevena |
| Lilly USA, LLC | $16.29 | 2024 | Jardiance, Zepbound |
| Baxter Healthcare | $15.98 | 2019 | |
| Conmed Corporation | $15.81 | 2025 | Abc Handpieces |
| Abbott Laboratories | $13.86 | 2022 | |
| Ermi LLC | $12.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Seibert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.